The association between polypharmacy and health-related quality of life among non-dialysis chronic kidney disease patients

BACKGROUND AND OBJECTIVE: The United States government spends over $85 billion annually on treating non-dialysis chronic kidney disease (CKD). Patients with CKD are prescribed a multitude of medications to manage numerous comorbidities associated with CKD. Thus, this study aims to investigate the as...

Descripción completa

Detalles Bibliográficos
Autores principales: Adjeroh, Leonie, Brothers, Todd, Shawwa, Khaled, Ikram, Mohammad, Al-Mamun, Mohammad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642842/
https://www.ncbi.nlm.nih.gov/pubmed/37956162
http://dx.doi.org/10.1371/journal.pone.0293912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642842/
https://www.ncbi.nlm.nih.gov/pubmed/37956162
http://dx.doi.org/10.1371/journal.pone.0293912

Ejemplares similares